{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:11:29Z","timestamp":1715955089067},"reference-count":12,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.transproceed.2010.06.019","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T04:24:13Z","timestamp":1290227053000},"page":"3735-3738","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of Bioequivalence of a Generic Cyclosporine (Equoral) by a Prospective Randomized Controlled Trial on Allogeneic Stem Cell Transplant Recipients"],"prefix":"10.1016","volume":"42","author":[{"given":"B.O.","family":"Tarek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.F.","family":"Nadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Saloua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Abderrahmane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lamia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Amel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.06.019_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.bmt.1705404","article-title":"Optimizing the use of cyclosporin in allogeneic stem cell transplantation","volume":"38","author":"Duncan","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2010.06.019_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2125.2008.03217.x","article-title":"Ciclosporin kinetics in children after stem cell transplantation","volume":"66","author":"Willemze","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2010.06.019_bib3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0041-1345(98)00385-6","article-title":"The pharmacokinetic of Oral Cyclosporine A (Neoral) during the first month after bone marrow transplantation","volume":"30","author":"Schultz","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.06.019_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0041-1345(02)03924-6","article-title":"Equoral, new cyclosporine drug delivery system, versus Neoral: a bioequivalence study in healthy volunteers","volume":"35","author":"Andreysek","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.06.019_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.transproceed.2003.11.007","article-title":"The pharmacokinetics of Equoral versus Neoral in stable renal transplant patient: a multicenter study","volume":"36","author":"Masri","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.06.019_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5507\/bp.2005.048","article-title":"Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients","volume":"149","author":"Franti\u0161ek","year":"2005","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.transproceed.2010.06.019_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bmt.1702375","article-title":"New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients","volume":"25","author":"Parquet","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2010.06.019_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharma.2008.03.003","article-title":"Therapeutic monitoring of immunosuppressive drugs: Interest of calcineurin activity assessment in liver transplantation","volume":"66","author":"Blanchet","year":"2008","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.transproceed.2010.06.019_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0253-7613.32522","article-title":"Therapeutic drug monitoring of immunosuppressants: an overview","volume":"39","author":"Tiwari","year":"2007","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.transproceed.2010.06.019_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/14622416.8.7.835","article-title":"Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update","volume":"7","author":"Anglichau","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.transproceed.2010.06.019_bib11","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0041-1345(99)00085-8","article-title":"Bioequivalence criteria for cyclosporine","volume":"31","author":"Johnston","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.06.019_bib12","first-page":"169","article-title":"Narrow therapeutic index drugs: bioequivalence and generics","volume":"39","author":"Le Core","year":"2010","journal-title":"Presse Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510012741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510012741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T13:59:52Z","timestamp":1544104792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510012741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0041134510012741"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.06.019","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}